These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 25301451)
1. Regulatory B cells accelerate hepatocellular carcinoma progression via CD40/CD154 signaling pathway. Shao Y; Lo CM; Ling CC; Liu XB; Ng KT; Chu AC; Ma YY; Li CX; Fan ST; Man K Cancer Lett; 2014 Dec; 355(2):264-72. PubMed ID: 25301451 [TBL] [Abstract][Full Text] [Related]
2. Perioperative dynamic alterations in peripheral regulatory T and B cells in patients with hepatocellular carcinoma. Chen T; Song D; Min Z; Wang X; Gu Y; Wei B; Yao J; Chen K; Jiang Z; Xie H; Zhou L; Zheng S J Transl Med; 2012 Jan; 10():14. PubMed ID: 22272696 [TBL] [Abstract][Full Text] [Related]
3. Dynamic analysis of tumor-associated immune cells in DEN-induced rat hepatocellular carcinoma. Song S; Yuan P; Li P; Wu H; Lu J; Wei W Int Immunopharmacol; 2014 Oct; 22(2):392-9. PubMed ID: 25066760 [TBL] [Abstract][Full Text] [Related]
4. Th17, synchronically increased with T Wang W; Wang Z; Qin Y; Tang G; Cai G; Liu Y; Zhang J; Zhang P; Shen Q; Shen L; Yu W Clin Exp Immunol; 2018 May; 192(2):181-192. PubMed ID: 29271479 [TBL] [Abstract][Full Text] [Related]
5. Suppression of actopaxin impairs hepatocellular carcinoma metastasis through modulation of cell migration and invasion. Ng L; Tung-Ping Poon R; Yau S; Chow A; Lam C; Li HS; Chung-Cheung Yau T; Law WL; Pang R Hepatology; 2013 Aug; 58(2):667-79. PubMed ID: 23504997 [TBL] [Abstract][Full Text] [Related]
6. Increased CD4(+) CD69(+) CD25(-) T cells in patients with hepatocellular carcinoma are associated with tumor progression. Zhu J; Feng A; Sun J; Jiang Z; Zhang G; Wang K; Hu S; Qu X J Gastroenterol Hepatol; 2011 Oct; 26(10):1519-26. PubMed ID: 21557772 [TBL] [Abstract][Full Text] [Related]
7. Intrahepatic interleukin-17+ T cells and FoxP3+ regulatory T cells cooperate to promote development and affect the prognosis of hepatocellular carcinoma. Huang Y; Wang F; Wang Y; Zhu Z; Gao Y; Ma Z; Xu R; Du Z J Gastroenterol Hepatol; 2014 Apr; 29(4):851-9. PubMed ID: 24303990 [TBL] [Abstract][Full Text] [Related]
8. Up-regulation of CD40 with juxtacrine activity in human nonsmall lung cancer cells correlates with poor prognosis. Ishikawa K; Miyamoto M; Yoshioka T; Kato T; Kaji M; Ohbuchi T; Hirano S; Itoh T; Dosaka-Akita H; Kondo S Cancer; 2008 Aug; 113(3):530-41. PubMed ID: 18548529 [TBL] [Abstract][Full Text] [Related]
9. Neuregulin/erythroblastic leukemia viral oncogene homolog 3 autocrine loop contributes to invasion and early recurrence of human hepatoma. Hsieh SY; He JR; Hsu CY; Chen WJ; Bera R; Lin KY; Shih TC; Yu MC; Lin YJ; Chang CJ; Weng WH; Huang SF Hepatology; 2011 Feb; 53(2):504-16. PubMed ID: 21246584 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma. Zhou SL; Dai Z; Zhou ZJ; Wang XY; Yang GH; Wang Z; Huang XW; Fan J; Zhou J Hepatology; 2012 Dec; 56(6):2242-54. PubMed ID: 22711685 [TBL] [Abstract][Full Text] [Related]
11. The activation of MEK/ERK signaling pathway by bone morphogenetic protein 4 to increase hepatocellular carcinoma cell proliferation and migration. Chiu CY; Kuo KK; Kuo TL; Lee KT; Cheng KH Mol Cancer Res; 2012 Mar; 10(3):415-27. PubMed ID: 22241220 [TBL] [Abstract][Full Text] [Related]
12. Foxp3+ regulatory T cells are associated with the natural history of chronic hepatitis B and poor prognosis of hepatocellular carcinoma. Wang F; Jing X; Li G; Wang T; Yang B; Zhu Z; Gao Y; Zhang Q; Yang Y; Wang Y; Wang P; Du Z Liver Int; 2012 Apr; 32(4):644-55. PubMed ID: 22118340 [TBL] [Abstract][Full Text] [Related]
13. Autogeneic rna-electroporated CD40-ligand activated b-cells from hepatocellular carcinoma patients induce CD8+ T-cell responses ex vivo. Shen S; Xu Z; Qian X; Ding Y; Yu L; Liu B Exp Oncol; 2007 Jun; 29(2):137-43. PubMed ID: 17704747 [TBL] [Abstract][Full Text] [Related]
14. Tumor-associated macrophage promotes tumor progression via STAT3 signaling in hepatocellular carcinoma. Mano Y; Aishima S; Fujita N; Tanaka Y; Kubo Y; Motomura T; Taketomi A; Shirabe K; Maehara Y; Oda Y Pathobiology; 2013; 80(3):146-54. PubMed ID: 23364389 [TBL] [Abstract][Full Text] [Related]
15. Tumor-derived exosomal HMGB1 fosters hepatocellular carcinoma immune evasion by promoting TIM-1 Ye L; Zhang Q; Cheng Y; Chen X; Wang G; Shi M; Zhang T; Cao Y; Pan H; Zhang L; Wang G; Deng Y; Yang Y; Chen G J Immunother Cancer; 2018 Dec; 6(1):145. PubMed ID: 30526680 [TBL] [Abstract][Full Text] [Related]
16. MUC15 inhibits dimerization of EGFR and PI3K-AKT signaling and is associated with aggressive hepatocellular carcinomas in patients. Wang RY; Chen L; Chen HY; Hu L; Li L; Sun HY; Jiang F; Zhao J; Liu GM; Tang J; Chen CY; Yang YC; Chang YX; Liu H; Zhang J; Yang Y; Huang G; Shen F; Wu MC; Zhou WP; Wang HY Gastroenterology; 2013 Dec; 145(6):1436-48.e1-12. PubMed ID: 23933603 [TBL] [Abstract][Full Text] [Related]
17. Increased liver-infiltrating CD8+FoxP3+ regulatory T cells are associated with tumor stage in hepatocellular carcinoma patients. Yang ZQ; Yang ZY; Zhang LD; Ping-Bie ; Wang SG; Ma KS; Li XW; Dong JH Hum Immunol; 2010 Dec; 71(12):1180-6. PubMed ID: 20870003 [TBL] [Abstract][Full Text] [Related]
18. PD-1hi Identifies a Novel Regulatory B-cell Population in Human Hepatoma That Promotes Disease Progression. Xiao X; Lao XM; Chen MM; Liu RX; Wei Y; Ouyang FZ; Chen DP; Zhao XY; Zhao Q; Li XF; Liu CL; Zheng L; Kuang DM Cancer Discov; 2016 May; 6(5):546-59. PubMed ID: 26928313 [TBL] [Abstract][Full Text] [Related]
19. Activated hepatic stellate cells promote hepatocellular carcinoma cell migration and invasion via the activation of FAK-MMP9 signaling. Han S; Han L; Yao Y; Sun H; Zan X; Liu Q Oncol Rep; 2014 Feb; 31(2):641-8. PubMed ID: 24284889 [TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo. Garcia MG; Bayo J; Bolontrade MF; Sganga L; Malvicini M; Alaniz L; Aquino JB; Fiore E; Rizzo MM; Rodriguez A; Lorenti A; Andriani O; Podhajcer O; Mazzolini G Mol Pharm; 2011 Oct; 8(5):1538-48. PubMed ID: 21770423 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]